PLPascal Lapierre

Pascal Lapierre

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Pascal Lapierre has a total of 110 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Predicting isoniazid resistance in Mycobacterium tuberculosis complex in New York State using whole-genome sequencing

    by Kruthikaben Patel, Joseph Shea, Pascal Lapierre, Tanya A. Halse, Donna Kohlerschmidt, Michelle Dickinson, Vincent Escuyer, Kimberlee A. Musser

    Isoniazid (INH) is a critical antibiotic used worldwide for the treatment and prophylaxis of tuberculosis. Drug resistance (DR) to INH is the single most common type of DR, mediated by multiple genes/loci, including katG, inhA, mabA, mabA-inhA, and the oxyR-ahpC intergenic region. Over the course of 6 years, we performed a two-phase study of 3,696 Mycobacterium tuberculosis complex (MTBC) strains, aiming to determine the molecular basis of INH resistance and assess whole-genome sequencing (WGS) for predicting resistance. In phase 1, we performed a side-by-side study, including 1,767 strains with paired phenotypic drug susceptibility testing (DST) and genotypic DST. We found WGS capable of accurately predicting INH resistance with a sensitivity of 90.3% and a specificity of 99.8%. The negative predictive value of WGS for INH susceptibility was 98.8%. Based on these findings, we developed a molecular testing algorithm where phenotypic DST (pDST) was reduced and applied this new testing algorithm in phase 2 to 1,929 MTBC strains, resulting in streamlined testing, reduced cost, and decreased turnaround time (TAT). The prevalence of INH resistance among MTBC strains in New York was found to be 10.2%. Of the 3,696 isolates tested, 337 were predicted INH-resistant by WGS. Of 41 additional strains exhibiting phenotypic INH resistance, 38 were found to have mutations in genes known to be associated with INH resistance. This study demonstrates the utility of WGS as a molecular tool for predicting INH DR and shows that the vast majority of INH resistance in MTBC has a molecular basis in known resistance loci. IMPORTANCE: Isoniazid (INH) is one of the two most critical antibiotics used as part of standard treatment of tuberculosis and is also used as preventative therapy for contacts of tuberculosis patients, despite having a higher rate of drug resistance than all other antibiotics used in standard therapy. Furthermore, isoniazid resistance typically precedes rifampin resistance in the development of multidrug-resistant TB. As such, the reliable detection of INH resistance is crucial for case management and to limit the acquisition of additional drug resistance. The present study describes a whole-genome sequencing approach to predicting INH resistance from clinical isolates and models how this technology can be used within a reduced phenotypic drug susceptibility testing algorithm to limit duplicate testing, saving resources and time while maintaining the sensitivity of resistance detection.


  • Open Access

    Mycobacterium abscessus research: learning from challenges

    by Ryan Z. Treen, Mercedes Gonzalez-Juarrero, Mary Jackson, Pascal Lapierre, Laurent Kremer, Pallavi Ghosh, Anil K. Ojha

    Mycobacterium abscessus (Mab), a rapidly growing mycobacterial species with intrinsic and acquired resistance to multiple antibiotics, is an emerging public health concern. The rise in clinical cases of treatment-refractory infections of M. abscessus has propelled its research toward novel therapeutic approaches. The number of publications entitled “ Mycobacterium abscessus” has increased by ~300% over the last decade, of which the majority of studies exploring the fundamental biology and pathogenesis of Mab have used the reference strain ATCC19977. However, whole-genome sequence analyses, combined with transposon-seq based functional genomics, reveal an open pan-genome with significant variations in the essential genes across ATCC19977 and clinical isolates. These new discoveries demand a careful selection of strains and growth conditions in experimental design. In this minireview, we discuss these challenges and propose a framework for future M. abscessus studies in silico , including a new web-based resource for pangenome analysis, in vitro, and in animal models.


  • Open Access

    Predicting Isoniazid Resistance in Mycobacterium tuberculosis Complex in New York State using Whole Genome Sequencing

    by Kruthika Patel, Joseph Shea, Pascal Lapierre, Tanya A. Halse, Donna Kohlerschmidt, Michelle Dickinson, Vincent Escuyer, Kimberlee A. Musser

    Isoniazid (INH) is a critical antibiotic used worldwide for treatment and prophylaxis of tuberculosis. Drug resistance (DR) to INH is the single most common type of DR, mediated by multiple genes/loci including katG, inhA, mabA, mabA-inhA and the oxyR-ahpC intergenic region. Over the course of 6 years, we performed a 2-phase study of 3,696 Mycobacterium tuberculosis complex (MTBC) strains aiming to determine the molecular basis of INH resistance and assess whole genome sequencing (WGS) for predicting resistance. In phase 1, we performed a side-by-side study including 1,767 strains with paired phenotypic drug susceptibility testing (DST) and genotypic DST. We found WGS capable of accurately predicting INH resistance with sensitivity of 90.3%, and specificity of 99.8%. The negative predictive value of WGS for INH susceptibility was 98.8%. Based on these findings, we developed a molecular testing algorithm where phenotypic DST was reduced and applied this new testing algorithm in phase 2 to 1,929 MTBC strains, resulting in streamlined testing, reduced cost and decreasing turnaround time (TAT). The prevalence of INH resistance among MTBC strains in New York was found to be 10.2%. Of the 3,696 isolates tested, 337 were predicted INH resistant by WGS. Of 41 additional strains exhibiting phenotypic INH resistance, 38 were found to have mutations in genes known to be associated with INH resistance. This study demonstrates the utility of WGS as a molecular tool for predicting INH DR and shows that the vast majority of INH resistance in MTBC has a molecular basis in known resistance loci.

  • Open Access

    iValiD-TB: a fully characterized Mycobacterium tuberculosis dataset for antimicrobial resistance bioinformatics workflow validations

    by Pascal Lapierre, Joseph Shea, Shannon G. Murphy, Carol Smith, Donna Kohlerschmidt, Michelle Dickinson, Kimberlee A. Musser, Vincent Escuyer, \R\Npascal Lapierre

  • Open Access

    A novel hybridization capture method for direct whole genome sequencing of clinical specimens to inform Legionnaires’ disease investigations

    by Phillip Weeber, Navjot Singh, Pascal Lapierre, Lisa Mingle, Danielle Wroblewski, Elizabeth J. Nazarian, Wolfgang Haas, Don Weiss, Kimberlee A. Musser

    The unprecedented precision and resolution of whole genome sequencing (WGS) can provide definitive identification of infectious agents for epidemiological outbreak tracking. WGS approaches, however, are frequently impeded by low pathogen DNA recovery from available primary specimens or unculturable samples. A cost-effective hybrid capture assay for Legionella pneumophila WGS analysis directly on primary specimens was developed. DNA from a diverse range of sputum and autopsy specimens PCR-positive for L. pneumophila serogroup 1 (LPSG1) was enriched with this method, and WGS was performed. All tested specimens were determined to be enriched for Legionella reads (up to 209,000-fold), significantly improving the discriminatory power to compare relatedness when no clinical isolate was available. We found the WGS data from some enriched specimens to differ by less than five single-nucleotide polymorphisms (SNPs) when compared to the WGS data of a matched culture isolate. This testing and analysis retrospectively provided previously unconfirmed links to environmental sources for clinical specimens of sputum and autopsy lung tissue. The latter provided the additional information needed to identify the source of these culture-negative cases associated with the South Bronx 2015 Legionnaires’ disease (LD) investigation in New York City. This new method provides a proof of concept for future direct clinical specimen hybrid capture enrichment combined with WGS and bioinformatic analysis during outbreak investigations. IMPORTANCE: Legionnaires’ disease (LD) is a severe and potentially fatal type of pneumonia primarily caused by inhalation of Legionella -contaminated aerosols from man-made water or cooling systems. LD remains extremely underdiagnosed as it is an uncommon form of pneumonia and relies on clinicians including it in the differential and requesting specialized testing. Additionally, it is challenging to obtain clinical lower respiratory specimens from cases with LD, and when available, culture requires specialized media and growth conditions, which are not available in all microbiology laboratories. In the current study, a method for Legionella pneumophila using hybrid capture by RNA baiting was developed, which allowed us to generate sufficient genome resolution from L. pneumophila serogroup 1 PCR-positive clinical specimens. This new approach offers an additional tool for surveillance of future LD outbreaks where isolation of Legionella is not possible and may help solve previously unanswered questions from past LD investigations.


  • Open Access

    Mycobacterium tuberculosis complex whole-genome sequencing in New York State: Implementation of a reduced phenotypic drug susceptibility testing algorithm

    by Joseph Shea, Tanya A. Halse, Herns Modestil, Cheryl Kearns, Randal C. Fowler, Cherry-Ann Da Costa-Carter, Ulrike Siemetzki-Kapoor, Melissa Leisner, Pascal Lapierre, Donna Kohlerschmidt, et al.


  • Open Access

    Genome-Wide Mapping of the Escherichia coli PhoB Regulon Reveals Many Transcriptionally Inert, Intragenic Binding Sites

    by Devon M. Fitzgerald, Anne M. Stringer, Carol Smith, Pascal Lapierre, Joseph T. Wade

    Recent studies have revealed large numbers of transcription factor binding sites within the genes of bacteria. The function, if any, of the vast majority of these binding sites has not been investigated.


  • Open Access

    Characterization of Mycobacterium salfingeri sp. nov.: A novel nontuberculous mycobacteria isolated from a human wound infection

    by Emily Musser, Carol Smith, Tanya A. Halse, Donna Kohlerschmidt, Amy Rourke, Alexandra Fiero, Kimberlee A. Musser, Vincent Escuyer, Pascal Lapierre

    Nontuberculous mycobacteria (NTM) are environmental bacteria commonly found in soil and water in almost every part of the world. While usually non-pathogenic, they can cause acute respiratory and cutaneous infections under certain circumstances or in patients with underlying medical conditions. Contrary to members of the Mycobacterium tuberculosis complex, documented human-to-human transmissions of NTM have been rarely reported and most cases result from direct environmental exposure. Here we describe the identification of a new NTM species isolated from a hand laceration of a New York State patient after a fall. This new NTM forms rough, orange pigmented colonies and is naturally resistant to doxycycline and tobramycin. Whole genome analysis reveal no close relatives present in public databases, and our findings are in accordance with the recognition of a new taxonomic species of NTM. We propose the name Mycobacterium salfingeri sp. nov. for this new NTM representative. The type strain is 20-157661T (DSM = 113368T, BCCM = ITM 501207T).